Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Eckert & Ziegler stock

EUZ.DE
DE0005659700
565970

Price

0
Today +/-
-0
Today %
-0 %

Eckert & Ziegler stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Eckert & Ziegler stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Eckert & Ziegler stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Eckert & Ziegler stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Eckert & Ziegler's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Eckert & Ziegler Stock Price History

DateEckert & Ziegler Price
12/18/20240 undefined
12/17/20240 undefined
12/16/20240 undefined
12/13/20240 undefined
12/12/20240 undefined
12/11/20240 undefined
12/10/20240 undefined
12/9/20240 undefined
12/6/20240 undefined
12/5/20240 undefined
12/4/20240 undefined
12/3/20240 undefined
12/2/20240 undefined
11/29/20240 undefined
11/28/20240 undefined
11/27/20240 undefined
11/26/20240 undefined
11/25/20240 undefined
11/22/20240 undefined
11/21/20240 undefined
11/20/20240 undefined
11/19/20240 undefined

Eckert & Ziegler Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eckert & Ziegler, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eckert & Ziegler from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eckert & Ziegler’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eckert & Ziegler. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eckert & Ziegler’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eckert & Ziegler’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eckert & Ziegler’s growth potential.

Eckert & Ziegler Revenue, EBIT and net profit per share

DateEckert & Ziegler RevenueEckert & Ziegler EBITEckert & Ziegler Net Income
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined

Eckert & Ziegler Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
00000000000000000000000000000
-----------------------------
-----------------------------
00000000000000000000000000000
00000000000000000000000000000
-----------------------------
00000000000000000000000000000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Eckert & Ziegler Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Eckert & Ziegler is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
                                                   
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Eckert & Ziegler provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Eckert & Ziegler's financial health and stability.

Assets

Eckert & Ziegler's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Eckert & Ziegler must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Eckert & Ziegler after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Eckert & Ziegler's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
--------------------------
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000

Eckert & Ziegler stock margins

The Eckert & Ziegler margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eckert & Ziegler. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eckert & Ziegler.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eckert & Ziegler's sales revenue. A higher gross margin percentage indicates that the Eckert & Ziegler retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eckert & Ziegler's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eckert & Ziegler's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eckert & Ziegler's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eckert & Ziegler. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eckert & Ziegler's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eckert & Ziegler Margin History

Eckert & Ziegler Gross marginEckert & Ziegler Profit marginEckert & Ziegler EBIT marginEckert & Ziegler Profit margin
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %
20040 %0 %0 %

Eckert & Ziegler Stock Sales Revenue, EBIT, Earnings per Share

The Eckert & Ziegler earnings per share therefore indicates how much revenue Eckert & Ziegler has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eckert & Ziegler earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eckert & Ziegler's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eckert & Ziegler’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eckert & Ziegler's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eckert & Ziegler Revenue, EBIT and net profit per share

DateEckert & Ziegler Sales per ShareEckert & Ziegler EBIT per shareEckert & Ziegler Earnings per Share
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined

Eckert & Ziegler business model

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler is one of the most popular companies on Eulerpool.com.

Eckert & Ziegler SWOT Analysis

Strengths

Eckert & Ziegler Strahlen und Medizintechnik AG possesses several strengths that contribute to its success. Firstly, the company has a strong reputation and brand recognition in the field of medical technology. This allows them to attract and retain a talented workforce, ensuring high-quality products and services. Additionally, their extensive experience in the industry has enabled them to develop a wide range of innovative and reliable products.

Weaknesses

Despite its strengths, Eckert & Ziegler Strahlen und Medizintechnik AG also faces certain weaknesses. One such weakness is its limited global presence compared to some of its competitors. This restricts their market reach and potential for growth in certain regions. Furthermore, the company heavily relies on a few key customers, which poses a risk in case of any disruptions in these relationships.

Opportunities

There are several opportunities available for Eckert & Ziegler Strahlen und Medizintechnik AG to explore. Expansion into emerging markets presents a promising avenue for growth, as these markets tend to have increasing demand for medical technologies. Moreover, the rise in healthcare expenditure and advancements in technology provide opportunities for the company to develop new and improved products.

Threats

Alongside opportunities, Eckert & Ziegler Strahlen und Medizintechnik AG also faces certain threats. Intense competition in the medical technology industry poses a challenge to the company's market share and profitability. Additionally, ever-changing regulations and compliance requirements can create hurdles for the company's operations. Economic uncertainties and geopolitical factors also pose potential risks that could impact the company's performance.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Eckert & Ziegler Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Eckert & Ziegler historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Eckert & Ziegler shares outstanding

The number of shares was Eckert & Ziegler in 2023 — This indicates how many shares 20.824 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eckert & Ziegler earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eckert & Ziegler's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eckert & Ziegler’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eckert & Ziegler's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eckert & Ziegler stock splits

In Eckert & Ziegler's history, there have been no stock splits.
Eckert & Ziegler does not pay out any dividends.
Eckert & Ziegler does not pay out any dividends.
Eckert & Ziegler does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Eckert & Ziegler.

Eckert & Ziegler latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20190 0  (-13.37 %)2019 Q4
9/30/20190 0  (-1 %)2019 Q3
3/31/20190 0  (52.57 %)2019 Q1
9/30/20130 0  (-22.61 %)2013 Q3
6/30/20130 0  (19.71 %)2013 Q2
3/31/20130 0  (-48.24 %)2013 Q1
9/30/20120 0  (-25.12 %)2012 Q3
6/30/20120 0  (23.24 %)2012 Q2
12/31/20110 0  (-16.67 %)2011 Q4
9/30/20110 0  (-27.03 %)2011 Q3
1
2

Eulerpool ESG Scorecard© for the Eckert & Ziegler stock

Eulerpool World ESG Rating (EESG©)

39/ 100

🌱 Environment

11

👫 Social

64

🏛️ Governance

43

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees36
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Eckert & Ziegler shareholders

%
Name
Stocks
Change
Date
31.16051 % Eckert Wagniskapital und Fr¿hphasenfinanzierung GmbH6,596,6806,7205/30/2024
2.87296 % Norges Bank Investment Management (NBIM)608,205-122,5549/27/2024
2.08150 % Janus Henderson Investors440,65309/30/2024
1.99098 % The Vanguard Group, Inc.421,4904,5389/30/2024
1.14973 % FIVV AG243,398-33,2122/29/2024
0.98926 % Amundi Asset Management, SAS209,4271,0859/30/2024
0.96269 % DWS Investment GmbH203,8028419/30/2024
0.94678 % BlackRock Institutional Trust Company, N.A.200,4333629/30/2024
0.88142 % Groupama Asset Management186,596-4,5517/31/2024
0.86117 % Dimensional Fund Advisors, L.P.182,3092138/31/2024
1
2
3
4
5
...
10

Eckert & Ziegler Executives and Management Board

Dr. Andreas Eckert

(63)
Eckert & Ziegler Chief Executive Officer, Chairman of the Executive Board
Compensation 901,370

Dr. Lutz Helmke

Eckert & Ziegler Member of the Executive Board, Business Segment Medical (Operations)
Compensation 555,025

Dr. Harald Hasselmann

(53)
Eckert & Ziegler Member of the Executive Board, Segment Medical (Distribution)
Compensation 543,105

Prof. Dr. Wolfgang Maennig

(63)
Eckert & Ziegler Independent Chairman of the Supervisory Board
Compensation 42,000

Mr. Frank Perschmann

(69)
Eckert & Ziegler Independent Member of the Supervisory Board (since 2019)
Compensation 36,250
1
2
3

Eckert & Ziegler Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
RaySearch Laboratories B Stock
RaySearch Laboratories B
SupplierCustomer0,08-0,42-0,310,140,61-0,20
Synektik Stock
Synektik
SupplierCustomer-0,040,300,480,530,430,56
Telix Pharmaceuticals Stock
Telix Pharmaceuticals
SupplierCustomer-0,240,380,690,860,450,74
1

Most common questions regarding Eckert & Ziegler

What values and corporate philosophy does Eckert & Ziegler represent?

Eckert & Ziegler Strahlen und Medizintechnik AG represents strong values and a clear corporate philosophy. This German company operates in the field of radiation therapy and medical technology, aiming to improve the quality of life for patients worldwide. Their core values include innovation, excellence, and sustainability. Eckert & Ziegler Strahlen und Medizintechnik AG fosters a culture of continuous improvement and invests in research and development to offer cutting-edge solutions. By prioritizing patient well-being, the company ensures the highest standards of quality and safety in their products and services. With a commitment to social and environmental responsibility, Eckert & Ziegler Strahlen und Medizintechnik AG strives to make a positive impact while delivering value to stakeholders.

In which countries and regions is Eckert & Ziegler primarily present?

Eckert & Ziegler Strahlen und Medizintechnik AG is primarily present in various countries and regions across the globe. With a strong international presence, the company operates in several key markets including Germany, the United States, France, Brazil, and Japan, among others. Its business activities span across Europe, North and South America, Asia, and other parts of the world. The global reach of Eckert & Ziegler Strahlen und Medizintechnik AG enables the company to cater to a diverse customer base, while continuously expanding its market share and leveraging its expertise in radiation and medical technology.

What significant milestones has the company Eckert & Ziegler achieved?

Eckert & Ziegler Strahlen und Medizintechnik AG, a renowned stock company in the medical technology sector, has achieved significant milestones over the years. The company has demonstrated its commitment to innovation and growth, establishing itself as a global leader. Notable achievements include the development of groundbreaking radiation therapy solutions, strategic partnerships with leading medical institutions, and consistent revenue growth. Eckert & Ziegler Strahlen und Medizintechnik AG's dedication to quality and cutting-edge advancements has earned them a strong reputation within the industry. These accomplishments solidify the company's position as a key player in the healthcare sector, driving further success and shareholder value.

What is the history and background of the company Eckert & Ziegler?

Eckert & Ziegler Strahlen und Medizintechnik AG is a renowned company with a rich history and background. Founded in Berlin, Germany in 1992, the company specializes in radiation therapy, isotope technology, and medical imaging. Eckert & Ziegler has become a global leader in the field, providing innovative solutions for the diagnosis and treatment of cancer and other diseases. With a strong focus on research and development, the company has continuously expanded its product portfolio and established a solid reputation for delivering high-quality and reliable medical technology. Eckert & Ziegler's commitment to excellence and dedication to improving healthcare has enabled it to become a trusted name in the industry.

Who are the main competitors of Eckert & Ziegler in the market?

The main competitors of Eckert & Ziegler Strahlen und Medizintechnik AG in the market include companies like Varian Medical Systems, Elekta AB, and IBA Molecular.

In which industries is Eckert & Ziegler primarily active?

Eckert & Ziegler Strahlen und Medizintechnik AG is primarily active in the radiation therapy and nuclear medicine industries.

What is the business model of Eckert & Ziegler?

The business model of Eckert & Ziegler Strahlen und Medizintechnik AG focuses on radiation technology and medical equipment. As a leading global provider, the company specializes in the development, production, and distribution of isotope technology, radiation therapy equipment, and radiopharmaceuticals. Eckert & Ziegler operates in various segments, including Isotope Products, Radiopharma, Treatment and Services, and Environmental Services. With a strong emphasis on innovation and quality, the company strives to meet the needs of medical professionals and improve patient care worldwide. Eckert & Ziegler's comprehensive range of products and services caters to the growing demand in the medical and industrial sectors.

What is the P/E ratio of Eckert & Ziegler 2024?

The P/E ratio cannot be calculated for Eckert & Ziegler at the moment.

What is the P/S ratio of Eckert & Ziegler 2024?

The P/S cannot be calculated for Eckert & Ziegler currently.

What is the Quality Investing of Eckert & Ziegler?

The Quality Investing for Eckert & Ziegler is 7/10.

What is the revenue of Eckert & Ziegler 2024?

The revenue cannot currently be calculated for Eckert & Ziegler.

How high is the profit of Eckert & Ziegler 2024?

The profit cannot currently be calculated for Eckert & Ziegler.

What is the business model of Eckert & Ziegler

The Eckert & Ziegler Strahlen und Medizintechnik AG is a globally operating provider of high-quality products and services in the field of radiation and medical technology. The company was founded in 1997 and is headquartered in Berlin. The business model of Eckert & Ziegler Strahlen und Medizintechnik AG is based on three main divisions: radiation therapy, isotope applications, and radiopharmaceuticals. Each division is focused on products and services specifically developed for its respective area. The radiation therapy division offers solutions for cancer treatment, including radioactive implants that are specifically inserted into the tumor, as well as radioactive sources for radiation devices. These measures can be used in both brachytherapy and teletherapy. Isotope applications include the development, production, and sale of isotopes for diagnostics and treatment of diseases. This includes radioactive markers for PET scanners, as well as radioactive capsules for thyroid treatment. The radiopharmaceutical division is another important pillar of the business model. Special medications containing radioactive substances are used to target specific areas of the body. Radiopharmaceuticals are primarily used in diagnostics and cancer treatment. In addition to the three main divisions, Eckert & Ziegler Strahlen und Medizintechnik AG also operates an extensive service and maintenance program for its products. This includes calibration of measuring devices, as well as commissioning and maintenance of radiation devices. The products of Eckert & Ziegler Strahlen und Medizintechnik AG are used worldwide in hospitals, research institutions, and the industry. The constant development of products and services is an important element of the business model. In summary, the business model of Eckert & Ziegler Strahlen und Medizintechnik AG is based on high-quality solutions in the field of radiation and medical technology. With its three main divisions and the service and maintenance program, the company offers a wide range of products and services that are used worldwide. The constant development of products and services, as well as a high customer orientation, are important success factors for the company.

What is the Eckert & Ziegler dividend?

Eckert & Ziegler pays a dividend of 0 EUR distributed over 1 payouts per year.

How often does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays out a dividend 1 times a year.

What is the Eckert & Ziegler ISIN?

The ISIN of Eckert & Ziegler is DE0005659700.

What is the Eckert & Ziegler WKN?

The WKN of Eckert & Ziegler is 565970.

What is the Eckert & Ziegler ticker?

The ticker of Eckert & Ziegler is EUZ.DE.

How much dividend does Eckert & Ziegler pay?

Over the past 12 months, Eckert & Ziegler paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eckert & Ziegler is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler?

The current dividend yield of Eckert & Ziegler is .

When does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler?

Eckert & Ziegler paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.22 %.

In which sector is Eckert & Ziegler located?

Eckert & Ziegler is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler in the year 2023?

In the year 2023, Eckert & Ziegler distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler pay out the dividend?

The dividends of Eckert & Ziegler are distributed in EUR.

All fundamentals about Eckert & Ziegler

Our stock analysis for Eckert & Ziegler Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.